Overview
Dr. Alumkal is the Wicha Family Professor of Oncology. He is the Leader of the Genitourinary Medical Oncology Section in the Hematology-Oncology Division and a Professor with tenure in the Department of Internal Medicine. He co-leads the Translational and Clinical Research Program in the Rogel Cancer Center. Dr. Alumkal’s main goal is to link laboratory and clinical scientists in order to develop more effective treatments for patients with advanced cancers, including men with prostate cancer whom he treats.Dr. Alumkal attended the University of Texas (UT) at Austin where he graduated summa cum laude with a B.A. in Biology. He attended medical school at Baylor College of Medicine. He completed internal medicine residency training at UT Southwestern Medical Center, where he also served as Chief Resident. He completed medical oncology training at Johns Hopkins University followed by a post-doctoral fellowship focused on cancer epigenetics at Johns Hopkins University. Subsequently, Dr. Alumkal joined Oregon Health & Science University from 2007-2019. There, Dr. Alumkal was the Co-Leader of the Prostate Cancer Section and the inaugural holder of the Wayne D. Kuni and Joan E. Kuni Foundation Endowed Chair for Prostate Cancer Research.Dr. Alumkal is a physician-scientist who was elected to the American Society for Clinical Investigation in 2019. The Alumkal Laboratory’s main emphasis is to understand how genes get turned off and on in advanced prostate cancers and how this process enables tumors to become resistant to standard treatments. The most important goals of Dr. Alumkal’s studies are to identify therapies that effectively target advanced prostate cancers and to conduct innovative clinical trials designed to validate the effectiveness of novel therapeutic agents.In his free time, Dr. Alumkal enjoys spending time with his two children and his wife Kathleen Kemmer—who is also a medical oncologist and faculty member in the Hematology-Oncology Division at the University of Michigan—reading, running, and watching/playing soccer.
Dr. Alumkal is highly rated in 2 conditions, according to our data. His top areas of expertise are Familial Prostate Cancer and Prostate Cancer.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Center Dr, Floor B1 Reception E, Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Alumkal has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Rogel Cancer Center
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC).
Rogel Cancer Center
Scott Schuetze is an Oncologist and an Internal Medicine provider in Ann Arbor, Michigan. Dr. Schuetze is highly rated in 30 conditions, according to our data. His top areas of expertise are Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma.
Rogel Cancer Center
Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is highly rated in 36 conditions, according to our data. Her top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Orchiectomy.
Frequently Asked Questions about Dr. Joshi J. Alumkal
How do I make an appointment with Dr. Joshi J. Alumkal?
You can book an appointment with Dr. Joshi J. Alumkal by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Joshi J. Alumkal a top-rated expert for Familial Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joshi J. Alumkal is classified as an Advanced expert for Familial Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Joshi J. Alumkal specialize in?
While Dr. Joshi J. Alumkal is a Oncology, they have specific expertise in Familial Prostate Cancer, Prostate Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Joshi J. Alumkal accept my insurance?
Dr. Joshi J. Alumkal accepts most major insurance plans, including Blue Cross Blue Shield and CareSource. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial Prostate CancerDr. Alumkal isAdvanced. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Alumkal isAdvanced. Learn about Prostate Cancer.